Sarcoma  >>  motesanib (AMG 706)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
motesanib (AMG 706) / Takeda
NCT00089960: Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

Completed
2
138
US
AMG 706
Amgen
Gastrointestinal Cancer
06/06
06/08
NCT00254267: Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors

Completed
2
35
Japan
AMG 706
Amgen, Takeda
Advanced Gastrointestinal Stromal Tumor
02/07
12/12
2004-002165-20: An open label study of AMG 706 in subjects with advanced gastrointestinal stromal tumors (GISTs) who developed progressive disease or relapsed while on Imatinib Mesylate.

Completed
2
20
Europe
AMG 706, AMG 706,
Amgen Inc, AMGEN
Gastrointestinal stromal tumour (GIST)
 
03/07

Download Options